185 related articles for article (PubMed ID: 34425054)
1. The Biological Effects of Pharmaceuticals in the Marine Environment.
Mezzelani M; Regoli F
Ann Rev Mar Sci; 2022 Jan; 14():105-128. PubMed ID: 34425054
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceuticals in the aquatic environments: Evidence of emerged threat and future challenges for marine organisms.
Mezzelani M; Gorbi S; Regoli F
Mar Environ Res; 2018 Sep; 140():41-60. PubMed ID: 29859717
[TBL] [Abstract][Full Text] [Related]
3. Presence of pharmaceuticals and their metabolites in wild-living aquatic organisms - Current state of knowledge.
Świacka K; Maculewicz J; Kowalska D; Caban M; Smolarz K; Świeżak J
J Hazard Mater; 2022 Feb; 424(Pt A):127350. PubMed ID: 34607031
[TBL] [Abstract][Full Text] [Related]
4. Emerging challenges of the impacts of pharmaceuticals on aquatic ecosystems: A diatom perspective.
Kock A; Glanville HC; Law AC; Stanton T; Carter LJ; Taylor JC
Sci Total Environ; 2023 Jun; 878():162939. PubMed ID: 36934940
[TBL] [Abstract][Full Text] [Related]
5. Mixtures of environmental pharmaceuticals in marine organisms: Mechanistic evidence of carbamazepine and valsartan effects on Mytilus galloprovincialis.
Mezzelani M; Peruzza L; d'Errico G; Milan M; Gorbi S; Regoli F
Sci Total Environ; 2023 Feb; 860():160465. PubMed ID: 36427727
[TBL] [Abstract][Full Text] [Related]
6. Levels and effects of antidepressant drugs to aquatic organisms.
Moreira DG; Aires A; de Lourdes Pereira M; Oliveira M
Comp Biochem Physiol C Toxicol Pharmacol; 2022 Jun; 256():109322. PubMed ID: 35272041
[TBL] [Abstract][Full Text] [Related]
7. Determination of the pharmaceuticals-nano/microplastics in aquatic systems by analytical and instrumental methods.
Pashaei R; Dzingelevičienė R; Abbasi S; Szultka-Młyńska M; Buszewski B
Environ Monit Assess; 2022 Jan; 194(2):93. PubMed ID: 35028740
[TBL] [Abstract][Full Text] [Related]
8. Occurrence and ecotoxicological assessment of pharmaceuticals: Is there a risk for the Mediterranean aquatic environment?
Desbiolles F; Malleret L; Tiliacos C; Wong-Wah-Chung P; Laffont-Schwob I
Sci Total Environ; 2018 Oct; 639():1334-1348. PubMed ID: 29929299
[TBL] [Abstract][Full Text] [Related]
9. Evaluating legacy contaminants and emerging chemicals in marine environments using adverse outcome pathways and biological effects-directed analysis.
Hutchinson TH; Lyons BP; Thain JE; Law RJ
Mar Pollut Bull; 2013 Sep; 74(2):517-25. PubMed ID: 23820191
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceuticals in the marine environment: What are the present challenges in their monitoring?
Branchet P; Arpin-Pont L; Piram A; Boissery P; Wong-Wah-Chung P; Doumenq P
Sci Total Environ; 2021 Apr; 766():142644. PubMed ID: 33077207
[TBL] [Abstract][Full Text] [Related]
11. Emerging contaminants in Belgian marine waters: single toxicant and mixture risks of pharmaceuticals.
Claessens M; Vanhaecke L; Wille K; Janssen CR
Mar Pollut Bull; 2013 Jun; 71(1-2):41-50. PubMed ID: 23643408
[TBL] [Abstract][Full Text] [Related]
12. Effects of pharmaceuticals and personal care products on marine organisms: from single-species studies to an ecosystem-based approach.
Prichard E; Granek EF
Environ Sci Pollut Res Int; 2016 Nov; 23(22):22365-22384. PubMed ID: 27617334
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceuticals in the environment: expected and unexpected effects on aquatic fauna.
Fabbri E
Ann N Y Acad Sci; 2015 Mar; 1340():20-8. PubMed ID: 25557669
[TBL] [Abstract][Full Text] [Related]
14. Health effects and risks associated with the occurrence of pharmaceuticals and their metabolites in marine organisms and seafood.
Madikizela LM; Ncube S
Sci Total Environ; 2022 Sep; 837():155780. PubMed ID: 35537516
[TBL] [Abstract][Full Text] [Related]
15. An Overview of Analytical Methods to Determine Pharmaceutical Active Compounds in Aquatic Organisms.
Gómez-Regalado MDC; Martín-Pozo L; Martín J; Santos JL; Aparicio I; Alonso E; Zafra-Gómez A
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364408
[TBL] [Abstract][Full Text] [Related]
16. Occurrence, bioaccumulation and toxicological effect of drugs of abuse in aquatic ecosystem: A review.
Chen L; Guo C; Sun Z; Xu J
Environ Res; 2021 Sep; 200():111362. PubMed ID: 34048744
[TBL] [Abstract][Full Text] [Related]
17. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment.
Santos LH; Araújo AN; Fachini A; Pena A; Delerue-Matos C; Montenegro MC
J Hazard Mater; 2010 Mar; 175(1-3):45-95. PubMed ID: 19954887
[TBL] [Abstract][Full Text] [Related]
18. Environmental Hazard of Anticancer Drugs: State of the Art and Future Perspective for Marine Organisms.
Ribeiro F; Costa-Lotufo L; Loureiro S; Pavlaki MD
Environ Toxicol Chem; 2022 Aug; 41(8):1793-1807. PubMed ID: 35622001
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceuticals in biota in the aquatic environment: analytical methods and environmental implications.
Huerta B; Rodríguez-Mozaz S; Barceló D
Anal Bioanal Chem; 2012 Nov; 404(9):2611-24. PubMed ID: 22678760
[TBL] [Abstract][Full Text] [Related]
20. The potential environmental risks of pharmaceuticals in Vietnamese aquatic systems: case study of antibiotics and synthetic hormones.
Thanh Thuy HT; Nguyen TD
Environ Sci Pollut Res Int; 2013 Nov; 20(11):8132-40. PubMed ID: 23943004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
